CompletedPhase 4ketamine

Geriatric Ketamine for Pain Management Study

Sponsored by Antonios Likourezos

NCT ID
NCT02673372
Target Enrollment
60 participants
Start Date
2016-04
Est. Completion
2018-04

About This Study

This research project is geared towards geriatric analgesia in the Emergency Department (ED) with a goal of reducing the administration of opioid pain medications to elderly patients, thereby avoiding the commonly occurring, severe side effects associated with such medications, including hypotension, respiratory depression, altered mental status, delirium, as well as nausea/vomiting and constipation. The primary outcome of the study will be difference in pain score from baseline to 30 minutes post-medication administration. This project has the potential to change and modify the ED approach to geriatric analgesia by virtue of minimizing the use of opioid administration in elderly patients. T

Conditions Studied

Pain

Interventions

  • Morphine
  • Ketamine

Eligibility

Age:65 Years - 120 Years
Healthy Volunteers:No
View full eligibility criteria
Inclusion Criteria:

* ED patients; 65 years of age and older; abdominal, flank, back, traumatic chest, neck or musculoskeletal pain; capacity to give verbal or written consent.

Exclusion Criteria:

* ED patients \<65 years old; altered mental status; presenting with headache, non-traumatic chest pain; allergy to morphine or ketamine; weight \<40kg or \>115kg, unstable vital signs (systolic blood pressure \<90 or \>180 mmHg; heart rate \<5 or \>150 beats per minute; and respirations \<8 or \>30 per minute), and past medical history of severe renal or hepatic insufficiency, alcohol or drug abuse or psychiatric illness; Patients with BMI\>40; severe COPD

Study Locations (1)

Maimonides Medical Center
Brooklyn, New York, United States

This trial is not recruiting

This study has completed enrollment. Check back for results or find similar trials.

Find recruiting trials
Data Source
ClinicalTrials.gov

Last updated from source